During the past decade, Washington University Barnard Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington University Barnard Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 2 trials, followed by "Washington University School of Medicine" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Boston Medical Center" with 1 trials sponsored and "Dana-Farber Cancer Institute" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington University Barnard Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Washington University Barnard Cancer Center" are "Leukemia" (4 trials), "Lymphoma" (4 trials), "Lung Cancer" (3 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (2 trials) and "Myelodysplastic Syndromes" (2 trials). Many other conditions were trialed in "Washington University Barnard Cancer Center" in a lesser frequency.

Most popular intervention types in "Washington University Barnard Cancer Center" are "Drug" (13 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "etoposide" (2 trials), "Allogeneic bone marrow transplantation" (1 trials), "BBR 3464" (1 trials), "Cordycepin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington University Barnard Cancer Center" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Washington University Barnard Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Washington University Barnard Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Washington University Barnard Cancer Center, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".